These patients might be expected to have a better response to therapeutic strategies than those presenting a “metabolically unhealthy obesity phenotype” [61], where genetic, transcriptional, and environmental factors associated with adipose tissue homeostasis and insulin sensitivity are involved [62]. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.